solver.press

Integrating evolutionary trade-off models from microbiology with active foam physics simulations will enable prediction of spatial patterns in the spread of antibiotic-resistant bacterial colonies.

BiologyApr 22, 2026Evaluation Score: 66%

Adversarial Debate Score

70% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

Grok: The hypothesis is falsifiable through simulation and experimental validation of spatial patterns, and it is partially supported by papers on evolutionary trade-offs in antibiotic resistance and active matter physics. However, the integration of these distinct fields lacks direct evidence in the p...
Mistral: The hypothesis is falsifiable and integrates well-supported concepts (evolutionary trade-offs, active matter physics), but counterarguments exist—e.g., compensatory mutations or environmental heterogeneity could undermine predictive accuracy. The papers provide partial but not exhaustive support.
ChatGPT: The hypothesis is falsifiable and builds on well-supported concepts—evolutionary trade-offs in resistance and active matter physics—but the cited papers stop short of directly integrating these fields or demonstrating predictive spatial models, making the claim plausible yet not fully substantiat...

Supporting Research Papers

Computational Result

📖 Literature-assessed (LLM)· literature_meta

An LLM's reading of the literature — not computational verification.

Integration of models shows promise but requires further validation.

Method: literature_meta · Result: inconclusive · Confidence: 60%

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

A hybrid computational model coupling (a) an evolutionary trade-off model of antibiotic resistance (parameterizing fitness cost of resistance vs. growth/motility rate under drug pressure) with (b) an active-matter/foam-physics simulation of colony mechanics (cell-cell jamming, interfacial tension, void/bubble-like microcolony packing) will predict spatial patterns of resistant-clone spread — specifically front velocity, clone-cluster size distribution, and spatial segregation index — in bacterial colonies grown under spatial antibiotic gradients, with prediction error (RMSE) on these three observables ≤20% relative to experimentally measured values across ≥3 independent drug-gradient conditions, outperforming a null model (pure reaction-diffusion Fisher-KPP without foam-physics mechanical coupling) by ≥30% reduction in RMSE.

Disproof criteria:
  • If coupled model RMSE on spatial pattern metrics is not significantly better (≤30% improvement, p>0.05, paired bootstrap) than the null Fisher-KPP reaction-diffusion model across the tested conditions, the hypothesis is disproven.
  • If the fitted mechanical parameters (effective surface tension, active pressure) required to match observed patterns are inconsistent with independently measured rheological/biophysical properties of the colony (i.e., parameters become non-physical fitting artifacts), this disproves the claimed mechanistic integration.
  • If prediction accuracy does not generalize across ≥2 distinct drug classes or ≥2 species (i.e., only fits via per-condition retuning), the general hypothesis (not just a single-case curve fit) is disproven.
  • Failure to reproduce known qualitative phenomena (e.g., resistant-clone sector formation, front roughening under mechanical stress) constitutes disproof of mechanistic validity even if bulk RMSE passes.

Spine & Adversarial ReadReady for validation

“This hypothesis tests whether coupling an evolutionary fitness-trade-off model of antibiotic resistance with an active-foam-physics model of colony mechanics predicts spatial resistant-clone patterns significantly better than a standard reaction-diffusion model alone.”

  • highSpatial patterns in bacterial colony expansion (sectoring, clone-cluster size distributions) are already well-explained by established population-genetics models of range expansion and genetic drift ('gene surfing', Hallatschek et al.) without invoking active-foam mechanics at all — the added mechanical complexity may be unnecessary and the hypothesis risks being a solution in search of a problem.
    The protocol explicitly includes an ablation (foam-physics-only vs. evolutionary-only vs. coupled) and a null Fisher-KPP/drift-based comparison to isolate whether mechanical coupling adds predictive power beyond drift/diffusion alone; however, the EVP does not yet include a dedicated stochastic gene-surfing null model (only deterministic Fisher-KPP), which is a gap — a genetic-drift stochastic null should be added as a second baseline to fully address this objection.
  • highWhy 'active foam physics' specifically, rather than simpler established colony-growth mechanical models (e.g., simple vertex models, Eden growth models, or existing biofilm mechanics frameworks)? The methodology does not justify why foam physics (with its bubble/void/coarsening analogy) is the correct mechanical framework versus alternatives, risking an arbitrary methodology choice.
    Partial justification: active foam models are chosen because they naturally incorporate active pressure from growth (analogous to bubble expansion) and jamming/T1-transition rearrangements observed in dense bacterial colonies, which simpler Eden-growth models lack. This justification is stated in the methodology but not empirically pre-validated against alternative mechanical frameworks (e.g., simple vertex model without 'foam' active-pressure terms) — a model-comparison step (foam vs. plain vertex vs. Eden growth) should be added to the protocol to defend the specific methodological choice rather than asserting it a priori.
  • mediumThe fitness-cost and resistance-mechanism scope (single efflux-pump mechanism, single species/drug in the MVT) is narrow; generalization claims across drug classes/species may not hold given how mechanism-specific fitness costs and resistance dynamics are, undermining the broader claim of a general predictive framework.
    The protocol addresses this partially via the generalization test (step 11, second drug class/species) and explicit failure criterion (RMSE>40% on generalization test triggers failure), but only two conditions are tested within the described budget — this is acknowledged as a boundary condition limitation rather than fully resolved; broader validation across more mechanisms would require additional funding beyond COST_USD_FULL estimate.

Experimental Protocol

Minimum viable test (MVT):

  1. Use one species (E. coli K-12 derivative), one resistance mechanism (efflux-pump-based, e.g., AcrAB-TolC overexpression) with known fitness cost (~2–10% growth rate reduction, from literature), one antibiotic (ciprofloxacin) in a radial gradient (disk diffusion or gradient plate).
  2. Grow colonies of mixed resistant/sensitive founder populations (labeled with distinct fluorescent reporters) for 48–72h, imaging every 2–4h with fluorescence microscopy to track spatial clone distribution.
  3. Independently parameterize: (i) evolutionary trade-off model (growth rate vs. resistance level, Hill-function dose-response) from monoculture assays; (ii) active foam physics model (jamming transition, effective viscosity, active pressure) from colony rheology/traction-force or particle-tracking microscopy on non-resistant colonies.
  4. Build coupled simulation (agent-based or continuum hybrid) predicting spatial clone pattern; compare against held-out experimental replicates (n≥8 plates) not used in parameterization.
  5. Compute RMSE, clone-cluster size distribution (KS-test), and segregation index against null (Fisher-KPP, no mechanical coupling) and against ablated model (mechanics only, no evolutionary trade-off).
Required datasets:
  • Time-lapse fluorescence microscopy images of dual-labeled (resistant/sensitive) bacterial colonies under antibiotic gradient (to be generated; no public dataset directly fits — nearest proxies: BioNumbers growth-rate databases, published E. coli fitness-cost tables for efflux/target mutations).
  • Rheological/mechanical parameters for bacterial colony "active foam" behavior (traction force microscopy datasets, e.g., from Volfson et al.-style colony mechanics studies — to be measured or taken from published biophysics literature).
  • Antibiotic diffusion coefficients in agar (standard microbiology reference tables, CLSI disk-diffusion zone data).
  • Simulation environment: custom agent-based model (e.g., built on CellModeller, PhysiCell, or BSim) extended with active-foam mechanical solver (e.g., adapted from existing active matter/vertex-model codebases).
  • Compute environment: Python/C++ simulation stack, GPU-accelerated particle/vertex model solver.
Success:
  • Coupled model RMSE ≤20% on front-velocity and cluster-size-distribution predictions on held-out data.
  • ≥30% RMSE reduction vs. null Fisher-KPP model (p<0.05).
  • Fitted mechanical parameters fall within independently measured physical ranges (±2x of literature/measured values), i.e. no non-physical overfitting.
  • Qualitative reproduction of at least 2 known emergent phenomena (sectoring, front roughening, or clone-size power-law scaling) confirmed by visual/statistical comparison.
  • Generalization: model (re-calibrated only on mechanical parameters, not re-fit on evolutionary trade-off) achieves ≤25% RMSE on second drug class/condition.
Failure:
  • RMSE improvement over null model <10% or not statistically significant.
  • Model requires per-condition re-fitting of evolutionary trade-off parameters to match each new gradient (indicating lack of true generalizable integration).
  • Fitted mechanical parameters diverge >5x from independently measured biophysical values.
  • Failure to reproduce basic qualitative colony patterns (sector formation) under any tested condition.
  • No improvement in generalization test (second drug/species) — RMSE >40%.

100

GPU hours

30d

Time to result

$1,000

Min cost

$10,000

Full cost

ROI Projection

Commercial:

Moderate-to-high niche value: licensable simulation platform for pharmaceutical companies designing spatial drug delivery (wound dressings, coated implants) and for public health modeling of resistance spread in hospital surfaces/biofilms. Estimated addressable market: infection-control simulation/consulting services ($5-20M niche market), plus academic tool licensing. Not a blockbuster commercial product but valuable as a predictive-modeling IP asset and grant-generating platform (NIH/NSF cross-disciplinary funding appeal due to Biology-Physics-Medicine crossover).

TIME_TO_RESULT_DAYS: 270

Implementation Sketch

# Pseudocode: Coupled Evolutionary-Foam Spatial Simulation

Initialize:
  grid = ContinuumField(drug_concentration, diffusion_coeff=D_drug)
  colony = AgentBasedOrVertexModel(cells)
  for cell in colony.cells:
      cell.genotype = sample(resistant_freq)
      cell.growth_rate_fn = TradeoffModel(genotype)  # from step 2 fit

TradeoffModel(genotype, drug_conc):
  cost = fitness_cost[genotype]  # empirically fit
  resistance_level = MIC[genotype]
  return baseline_growth_rate * (1 - cost) * HillInhibition(drug_conc, resistance_level)

FoamPhysicsStep(colony):
  compute local_density, packing_fraction
  compute active_pressure = f(local_growth_rate, packing_fraction)
  update cell positions via force-balance (vertex model / SPH-like active foam solver)
  handle jamming/rearrangement events (T1 transitions)

MainLoop (per timestep dt):
  grid.diffuse(dt)
  for cell in colony.cells:
      local_drug = grid.sample(cell.position)
      cell.growth_rate = TradeoffModel(cell.genotype, local_drug)
      cell.grow_or_divide(cell.growth_rate, dt)
  FoamPhysicsStep(colony)
  record spatial_pattern_metrics(colony)

PostProcess:
  compute front_velocity, cluster_size_distribution, segregation_index
  compare to experimental_data (RMSE, KS-test)
  compare to null_model (Fisher-KPP only, no mechanics)
Abort checkpoints:
  • Checkpoint 1 (Day 45): If monoculture dose-response fitting fails to produce a stable, reproducible trade-off curve (R²<0.6), abort/redesign before mechanics work begins.
  • Checkpoint 2 (Day 90): If colony mechanical characterization (PIV/rheology) shows packing fraction/jamming regime is not reached under experimental conditions (colonies too sparse), abort — active foam model inapplicable.
  • Checkpoint 3 (Day 150): If initial calibrated coupled model on training data fails to beat null model by >15% (interim threshold, half of final 30% target), reassess before committing to full held-out validation and generalization testing.
  • Checkpoint 4 (Day 210): If fitted mechanical parameters are already >3x outside physically measured ranges at calibration stage, abort before running expensive held-out and cross-species generalization tests.

NAMED_EXPERTS: []

CLOSEST_EXISTING_WORK: []

NOVELTY_NARROWING_REQUIRED: false

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started